Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Xianfei He"'
Autor:
Hang Ke, Tao Yang, Faming Zhang, Cen Chen, Jingjing Wang, Jinping Liu, Xiaoyu An, Lingxin Xiong, Xianfei He, Lei Zhang, Qi-Xiang Li
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Certain immune-checkpoint inhibitors have a narrow therapeutic window (TW) as cancer therapeutics, and engineered dual-/multi-targeting agents could potentially widen the TW to bring true clinical benefits. We report a new rationally-designe
Externí odkaz:
https://doaj.org/article/ca9ac7b4a1eb404fab5c23f987819202
Publikováno v:
Thoracic Cancer, Vol 12, Iss 12, Pp 1900-1908 (2021)
Abstract Background The cylindromatosis (CYLD) tumor suppressor is a microtubule‐associated deubiquitinase that plays a critical role in the regulation of cell signaling and contributes to a variety of physiological and pathological processes. Howe
Externí odkaz:
https://doaj.org/article/b12788e18d7248bba75c9ac9d6eaf4e1
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94496 (2014)
The innate immune system is the first line of host defense against infection and involves several different cell types. Here we investigated the role of the phosphatidylinositol 3 kinase (PI3K) signaling pathway in innate immune cells. By blocking th
Externí odkaz:
https://doaj.org/article/8f87e47bc79d4049b8cb76d5517fa9d8
Autor:
Xiaoyu An, Henry Li, Hang Ke, Lingxin Xiong, Faming Zhang, Mingfa Zang, Xiaolong Tu, Jingjing Wang, Demi Liu, Cen Chen, Cunxiang Ju, Xianfei He, Lei Zhang
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 12, Pp 1900-1908 (2021)
Thoracic Cancer, Vol 12, Iss 12, Pp 1900-1908 (2021)
Background The cylindromatosis (CYLD) tumor suppressor is a microtubule‐associated deubiquitinase that plays a critical role in the regulation of cell signaling and contributes to a variety of physiological and pathological processes. However, the
Autor:
Tao Yang, Rongfei Lu, Xiaofei Xu, Likun Zhang, Dawei Wang, Xinhe Feng, Xiaoyu An, Jessie (Jingjing) Wang, Xianfei He, Carl K. Edwards
Publikováno v:
Cancer Research. 83:5133-5133
Background. Th2 cytokines (e.g. IL-4, IL-5, IL13) drive defined allergic reactions and various autoimmune and inflammatory diseases including atopic dermatitis (AD), asthma and rhinitis. IL-4Ra is a receptor shared by both IL-4 and IL-13, thus blocki
Publikováno v:
Cancer Research. 82:615-615
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer therapy landscape in recent years. Despite the success of the checkpoint blockade strategies targeting cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death recep
Autor:
Lihong Yang, Qingchao Li, Te Li, Tao Zhong, Wei Xie, Yan Zhang, Min Liu, Jun Zhou, Song Yang, Jie Feng, Dengwen Li, Xianfei He, Songbo Xie
Publikováno v:
Experimental cell research. 387(1)
Microtubule-binding proteins provide an alternative and vital pathway to the functional diversity of microtubules. Considerable work is still required to understand the complexities of microtubule-associated cellular processes and to identify novel m
Autor:
Ruilin Sun, Henry Q. X. Li, Daniel Xianfei He, Annie Xiaoyu An, Chenpan Nie, Cunxiang Ju, Davy Xuesong Ouyang, Lei Zheng, Mingkun Zhang
Publikováno v:
Cancer Research. 80:5614-5614
Introduction: Ample clinical and preclinical evidence have shown the remarkable antitumor effects of anti-PD-1 antibodies. However, the fact that only around 20% of patients respond to anti-PD-1 immunotherapy indicates that additional inhibitory circ